Genetic Predisposition to Type 2 Diabetes and Risk of Subclinical Atherosclerosis and Cardiovascular Diseases Among 160,000 Chinese Adults
Open accessThe DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Abstract
In observational studies, type 2 diabetes is associated with two- to fourfold higher risk of cardiovascular diseases (CVD). Using data from the China Kadoorie Biobank (CKB), we examined associations of genetically predicted type 2 diabetes with CVD among ∼160,000 participants to assess whether these relationships are causal. A type 2 diabetes genetic risk score (comprising 48 established risk variants) was associated with the presence of carotid plaque (odds ratio 1.17 [95% CI 1.05, 1.29] per 1 unit higher log-odds of type 2 diabetes; n = 6,819) and elevated risk of ischemic stroke (IS) (1.08 [1.02, 1.14]; n = 17,097), nonlacunar IS (1.09 [1.03, 1.16]; n = 13,924), and major coronary event (1.12 [1.02, 1.23]; n = 5,081). There was no significant association with lacunar IS (1.03 [0.91, 1.16], n = 3,173) or intracerebral hemorrhage (ICH) (1.01 [0.94, 1.10], n = 6,973), although effect estimates were imprecise. These associations were consistent with observational associations of type 2 diabetes with CVD in CKB (P for heterogeneity >0.3) and with the associations of type 2 diabetes with IS, ICH, and coronary heart disease in two-sample Mendelian randomization analyses based on summary statistics from European population genome-wide association studies (P for heterogeneity >0.2). In conclusion, among Chinese adults, genetic predisposition to type 2 diabetes was associated with atherosclerotic CVD, consistent with a causal association.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bowden, J., Davey Smith, G., & Burgess, S. (2015) · International Journal of Epidemiology · doi:10.1093/ije/dyv080 · Cited by 9,816 · cited 2×
“Sensitivity analyses using weighted median, weighted mode, and MR-Egger approaches showed similar findings, as did analyses based on GRS-T2D86, and there was no evidence of unbalanced pleiotropy (P for pleiotropy from MR-Egger$0.31) (Supplementary Fig.”
MethodInfluentialBowden, J., Davey Smith, G., Haycock, P. C., & Burgess, S. (2016) · Genetic Epidemiology · doi:10.1002/gepi.21965 · Cited by 8,922 · cited 1×
“Additional sensitivity analyses, assessing the robustness of the twosample MR results, included 1) MR-Egger (36), 2) weighted median MR (37), and 3) weighted-mode MR (38).”
MethodThe MR-Base platform supports systematic causal inference across the human phenome
Hemani, G., Zheng, J., Elsworth, B., Wade, K. H., Haberland, V., Baird, D., Laurin, C., Burgess, S., Bowden, J., Langdon, R., et al. (2018) · eLife · doi:10.7554/elife.34408 · Cited by 7,959 · cited 1×
“Two-sample MR analysis was performed using the R TwoSampleMR package (35).”
MethodThe Emerging Risk Factors Collaboration (2010) · The Lancet · doi:10.1016/s0140-6736(10)60484-9 · Cited by 5,125 · cited 3×
“Large prospective observational studies have reported 30–60% higher risks of ICH in diabetes (3,4).”
Robust inference in summary data Mendelian randomization via the zero modal pleiotropy assumption
Hartwig, F. P., Davey Smith, G., & Bowden, J. (2017) · International Journal of Epidemiology · doi:10.1093/ije/dyx102 · Cited by 3,485
A comprehensive 1000 Genomes–based genome-wide association meta-analysis of coronary artery disease
the CARDIoGRAMplusC4D Consortium (2015) · Nature Genetics · doi:10.1038/ng.3396 · Cited by 2,447
Human Demographic History Impacts Genetic Risk Prediction across Diverse Populations
Martin, A. R., Gignoux, C. R., Walters, R. K., Wojcik, G. L., Neale, B. M., Gravel, S., Daly, M. J., Bustamante, C. D., & Kenny, E. E. (2017) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2017.03.004 · Cited by 1,391
Self-citationType 2 diabetes and incidence of cardiovascular diseases: a cohort study in 1.9 million people
Shah, A. D., Langenberg, C., Rapsomaniki, E., Denaxas, S., Pujades-Rodriguez, M., Gale, C. P., Deanfield, J., Smeeth, L., Timmis, A., & Hemingway, H. (2015) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(14)70219-0 · Cited by 1,225
The genetic architecture of type 2 diabetes
Fuchsberger, C., Flannick, J., Teslovich, T. M., Mahajan, A., Agarwala, V., Gaulton, K. J., Ma, C., Fontanillas, P., Moutsianas, L., McCarthy, D. J., et al. (2016) · Nature · doi:10.1038/nature18642 · Cited by 1,051 · cited 3×
“Externally weighted (28,29) GRS-IR (P 5 4.”
MethodSelf-citationChen, Z., Chen, J., Collins, R., Guo, Y., Peto, R., Wu, F., Li, L., & on behalf of the China Kadoorie Biobank (CKB) collaborative group (2011) · International Journal of Epidemiology · doi:10.1093/ije/dyr120 · Cited by 1,034
Self-citationDIAbetes Genetics Replication And Meta-analysis (DIAGRAM) Consortium, Mahajan, A., Asian Genetic Epidemiology Network Type 2 Diabetes (AGEN-T2D) Consortium, South Asian Type 2 Diabetes (SAT2D) Consortium, Mexican American Type 2 Diabetes (MAT2D) Consortium, Type 2 Diabetes Genetic Exploration by Next-generation sequencing in multi-Ethnic Samples (T2D-GENES) Consortium, Go, M. J., Zhang, W., Below, J. E., Gaulton, K. J., et al. (2014) · Nature Genetics · doi:10.1038/ng.2897 · Cited by 1,034
Self-citationLi, G., Zhang, P., Wang, J., An, Y., Gong, Q., Gregg, E. W., Yang, W., Zhang, B., Shuai, Y., Hong, J., et al. (2014) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(14)70057-9 · Cited by 684
Self-citationHemmingsen, B., Lund, S. S., Gluud, C., Vaag, A., Almdal, T., Hemmingsen, C., & Wetterslev, J. (2011) · BMJ · doi:10.1136/bmj.d6898 · Cited by 386 · cited 1×
“Although randomized controlled trials can assess causality, existing trial evidence for the effects of intensive glycemic control in diabetes (9), and of interventions to reduce or delay progression of prediabetes to diabetes (10,11), on risk of CVD is inconclusive.”
BackgroundGenetic variation near IRS1 associates with reduced adiposity and an impaired metabolic profile
Kilpeläinen, T. O., Zillikens, M. C., Stančákova, A., Finucane, F. M., Ried, J. S., Langenberg, C., Zhang, W., Beckmann, J. S., Luan, J., Vandenput, L., et al. (2011) · Nature Genetics · doi:10.1038/ng.866 · Cited by 335 · cited 1×
“Several type 2 diabetes risk–increasing variants have been associated with lower adiposity (28,45,46), potentially reflecting the associations of insulin resistance with higher risk of type 2 diabetes and propensity to visceral, rather than peripheral, adiposity (47).”
BackgroundSelf-citationWoo, D., Falcone, G. J., Devan, W. J., Brown, W. M., Biffi, A., Howard, T. D., Anderson, C. D., Brouwers, H. B., Valant, V., Battey, T. W. K., et al. (2014) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2014.02.012 · Cited by 290
Hopper, I., Billah, B., Skiba, M., & Krum, H. (2011) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1177/1741826711421687 · Cited by 149 · cited 1×
“Although randomized controlled trials can assess causality, existing trial evidence for the effects of intensive glycemic control in diabetes (9), and of interventions to reduce or delay progression of prediabetes to diabetes (10,11), on risk of CVD is inconclusive.”
BackgroundRisk factors for lacune subtypes in the Atherosclerosis Risk in Communities (ARIC) Study
Bezerra, D. C., Sharrett, A. R., Matsushita, K., Gottesman, R. F., Shibata, D., Mosley, T. H., Coresh, J., Szklo, M., Carvalho, M. S., & Selvin, E. (2012) · Neurology · doi:10.1212/wnl.0b013e31823efc42 · Cited by 114 · cited 1×
“Previous observational study findings on the association of type 2 diabetes with risk of IS subtypes have been conflicting (41,42).”
Background
Cited by
Heart Disease and Stroke Statistics—2023 Update: A Report From the American Heart Association
Tsao, C. W., Aday, A. W., Almarzooq, Z. I., Anderson, C. A. M., Arora, P., Avery, C. L., Baker-Smith, C. M., Beaton, A. Z., Boehme, A. K., Buxton, A. E., et al. (2023) · Circulation · doi:10.1161/cir.0000000000001123 · Cited by 8,300
Heart Disease and Stroke Statistics—2022 Update: A Report From the American Heart Association
Tsao, C. W., Aday, A. W., Almarzooq, Z. I., Alonso, A., Beaton, A. Z., Bittencourt, M. S., Boehme, A. K., Buxton, A. E., Carson, A. P., Commodore-Mensah, Y., et al. (2022) · Circulation · doi:10.1161/cir.0000000000001052 · Cited by 5,987
Heart Disease and Stroke Statistics—2021 Update: A Report From the American Heart Association
Virani, S. S., Alonso, A., Aparicio, H. J., Benjamin, E. J., Bittencourt, M. S., Callaway, C. W., Carson, A. P., Chamberlain, A. M., Cheng, S., Delling, F. N., et al. (2021) · Circulation · doi:10.1161/cir.0000000000000950 · Cited by 5,784
Self-citationMartin, S. S., Aday, A. W., Almarzooq, Z. I., Anderson, C. A. M., Arora, P., Avery, C. L., Baker-Smith, C. M., Barone Gibbs, B., Beaton, A. Z., Boehme, A. K., et al. (2024) · Circulation · doi:10.1161/cir.0000000000001209 · Cited by 2,800
Martin, S. S., Aday, A. W., Allen, N. B., Almarzooq, Z. I., Anderson, C. A. M., Arora, P., Avery, C. L., Baker-Smith, C. M., Bansal, N., Beaton, A. Z., et al. (2025) · Circulation · doi:10.1161/cir.0000000000001303 · Cited by 1,080
Metadata
- Authors
- Gan, W., Bragg, F., Walters, R. G., Millwood, I. Y., Lin, K., Chen, Y., Guo, Y., Vaucher, J., Bian, Z., Bennett, D., Lv, J., Yu, C., Mahajan, A., Clarke, R. J., Li, L., Holmes, M. V., McCarthy, M. I., Chen, Z., China Kadoorie Biobank Collaborative Group, Chen, J., Chen, Z., Clarke, R., Collins, R., Guo, Y., Li, L., Lv, J., Peto, R., Walters, R., Avery, D., Bennett, D., Boxall, R., Bragg, F., Chang, Y., Chen, Y., Du, H., Gilbert, S., Hacker, A., Holmes, M., Iona, A., Kartsonaki, C., Kerosi, R., Kurmi, O., Lewington, S., Lancaster, G., Lin, K., McDonnell, J., Millwood, I., Nie, Q., Radhakrishnan, J., Ryder, P., Sansome, S., Schmidt, D., Sherliker, P., Sohoni, R., Stevens, B., Turnbull, I., Wang, J., Wang, L., Wright, N., Yang, L., Yang, X., Bian, Z., Chen, G., Han, X., Hou, C., Pei, P., Qu, S., Tan, Y., Yu, C., Pang, Z., Gao, R., Wang, S., Liu, Y., Du, R., Zang, Y., Cheng, L., Tian, X., Zhang, H., Lv, S., Wang, J., Hou, W., Yin, J., Jiang, G., Zhou, X., Yang, L., He, H., Yu, B., Li, Y., Mu, H., Xu, Q., Dou, M., Ren, J., Wang, S., Hu, X., Wang, H., Chen, J., Fu, Y., Fu, Z., Wang, X., Weng, M., Zheng, X., Li, Y., Li, H., Wang, Y., Wu, M., Zhou, J., Tao, R., Yang, J., Ni, C., Zhang, J., Hu, Y., Lu, Y., Ma, L., Tang, A., Zhang, S., Jin, J., Liu, J., Tang, Z., Chen, N., Huang, Y., Li, M., Meng, J., Pan, R., Jiang, Q., Zhang, W., Liu, Y., Wei, L., Zhou, L., Chen, N., Guan, H., Wu, X., Zhang, N., Chen, X., Tang, X., Luo, G., Li, J., Zhong, X., Liu, J., Sun, Q., Ge, P., Ren, X., Dong, C., Zhang, H., Mao, E., Wang, X., Wang, T., Zhang, X., Zhang, D., Zhou, G., Feng, S., Chang, L., Fan, L., Gao, Y., He, T., Sun, H., He, P., Hu, C., Lv, Q., Zhang, X., Yu, M., Hu, R., Wang, H., Qian, Y., Wang, C., Xie, K., Chen, L., Zhang, Y., Pan, D., Huang, Y., Chen, B., Yin, L., Jin, D., Liu, H., Fu, Z., Xu, Q., Xu, X., Zhang, H., Xiong, Y., Long, H., Li, X., Zhang, L., & Qiu, Z.
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2019-08-09
- Volume
- 68
- Issue
- 11
- Pages
- 2155-2164
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- OpenAlex
- W2967096050
- Cited by
- 64
- References
- 17
- FWCI
- 4.20
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.